This test is most useful if any of these apply to you.
If your calcium has been drifting up or down without an obvious cause, or your kidneys are not working as well as they used to, the form of vitamin D that actually does the work in your body is worth measuring directly. This test looks at calcitriol, the hormone your kidneys make from stored vitamin D, which decides how much calcium your gut absorbs and how your bones, blood vessels, and immune cells respond.
Most people only ever check the storage form of vitamin D, called 25(OH)D (25-hydroxyvitamin D). That tells you what is sitting in the bank. This test, 1,25(OH)2D (1,25-dihydroxyvitamin D), tells you what your body is actually spending. The two numbers can move in opposite directions, and that gap is where the interesting clinical information lives.
Vitamin D from sun or food first travels to the liver, where it becomes 25(OH)D. That is the form a standard vitamin D blood test measures. To do anything useful, 25(OH)D then has to travel to the kidneys, where an enzyme called CYP27B1 turns it into the active hormone 1,25(OH)2D. Some immune cells and other tissues can also make small amounts locally.
Your body keeps 1,25(OH)2D under tight hormonal control. Parathyroid hormone (PTH), calcium, phosphate, and a bone-derived hormone called FGF23 all push it up or down over the course of hours. Because of this, 1,25(OH)2D can stay in a normal range even when your stored 25(OH)D is low, which is exactly why 25(OH)D, not 1,25(OH)2D, is the right test for everyday vitamin D status.
So why measure it at all? Because in certain situations the active hormone tells you something the storage form cannot. When your kidneys lose the ability to make 1,25(OH)2D, when overactive immune tissue makes too much of it, or when a drug interferes with the FGF23 system, 1,25(OH)2D moves before anything else explains why. This is a specialized test for a specific question, not a routine vitamin D screen.
Your kidneys are the main factory for active vitamin D. As kidney function falls, 1,25(OH)2D production falls with it, often before standard kidney numbers look alarming. In a study of 1,099 adults with advanced kidney disease, lower plasma 1,25(OH)2D was linked to a higher risk of death and progression to dialysis, even after accounting for kidney function.
The heart suffers too. In 513 people with chronic kidney disease, lower 1,25(OH)2D was independently associated with a thicker, stiffer left heart chamber and worse relaxation of that chamber. The standard 25(OH)D test did not show the same pattern in this group. This is one of the clearest places where the active hormone reveals something the storage form misses.
1,25(OH)2D is the main hormone telling your gut to absorb calcium. When calcium runs low, PTH rises and tells the kidneys to make more 1,25(OH)2D. When something pushes 1,25(OH)2D too high, calcium absorption climbs and PTH falls. Measuring 1,25(OH)2D alongside calcium and PTH helps locate where in this loop something is off.
In a large study of 2,783 middle-aged and older men, the combination of high 1,25(OH)2D with low 25(OH)D was linked to poorer bone outcomes than either reading alone. The pattern suggests a bone system working overtime to compensate, which is a different problem than simple vitamin D shortage. The two measurements together give you the phenotype, not just a status check.
A common surprise: someone can have normal or low 25(OH)D but unusually high 1,25(OH)2D, or vice versa. This is not a paradox once you understand the framework. 1,25(OH)2D is a phenotype indicator, not a fuel gauge. High active hormone with low storage form often means your parathyroid system is working hard to compensate. Low active hormone with adequate storage often means the kidneys cannot keep up the conversion. The right interpretation depends on the whole panel, not the 1,25(OH)2D number in isolation.
Inflammation, surgical stress, and serious infection drag 1,25(OH)2D down. In a study of 91 adults with sepsis, those who died within 30 days had significantly lower 1,25(OH)2D at admission. The standard 25(OH)D test, in the same patients, did not separate survivors from non-survivors.
Similar patterns show up in cardiac surgery (n=92) and in 508 people preparing for stem cell transplantation, where pre-procedure 1,25(OH)2D predicted one-year survival while 25(OH)D did not. This is why some hospital and transplant teams now check the active hormone before high-risk procedures. It is not a routine reading, but it carries weight in specific settings.
Vitamin D receptors live inside skeletal muscle fibers, and the active hormone is the form that binds them. In a study comparing the two forms of vitamin D in human muscle function, serum 1,25(OH)2D correlated more closely with lower-limb power and lean mass than 25(OH)D did. Storage form influenced muscle mostly through body fat, while the active hormone had a more direct link.
The story for blood pressure is less tidy. In the PREVEND study of 5,066 adults, higher plasma 1,25(OH)2D was linked to a higher, not lower, risk of developing hypertension over time. This runs against the common assumption that more vitamin D is always better. Because 1,25(OH)2D is hormonally regulated, a high reading in an otherwise healthy person may reflect a system working harder to maintain balance, not a state of abundance. This is another reason single readings should not drive decisions in isolation.
1,25(OH)2D swings with PTH, calcium intake, hydration, illness, and kidney function. Lab measurement of it carries meaningful variation: newer automated assays show analytical imprecision of roughly 4 to 7%, while older assays ran 12 to 20%, and the natural biological variation within the same person is about 22%. That means a single number near a decision threshold is not reliable on its own. Get a baseline. If something looks off, retest in clinical stability, ideally with 25(OH)D, PTH, calcium, phosphate, and a marker of kidney function (creatinine or cystatin C) drawn at the same time.
If you have known kidney disease or are taking active vitamin D medications, retest at least annually and any time symptoms or other labs shift. If you started a supplement or a new medication that affects the FGF23 or phosphate system, give it a few weeks to settle, then retest. A trend across two or three readings will tell you something a single value cannot.
Several factors can shift a single 1,25(OH)2D reading without changing your underlying health:
An out-of-pattern 1,25(OH)2D is rarely actionable on its own. The next move is almost always to look at the full mineral picture. Pair an unexpected result with 25(OH)D, intact PTH, calcium, phosphate, and a kidney function marker (creatinine, cystatin C, or eGFR). The combination tells you whether the active hormone is high or low because of kidney function, parathyroid activity, an immune process making vitamin D outside the kidneys, or a drug effect.
If 1,25(OH)2D is high with high calcium and suppressed PTH, that pattern can suggest a granulomatous condition (such as sarcoidosis) or certain lymphomas making vitamin D outside the kidneys, and it warrants specialist input. If 1,25(OH)2D is low with reduced kidney function and rising PTH, the workup belongs with a nephrologist. If it is low with normal kidneys but ongoing infection or severe illness, the underlying condition usually needs attention first. A repeat reading once you are stable is more informative than chasing the original number.
Evidence-backed interventions that affect your Calcitriol level
Vitamin D (1,25-dihydroxy) is best interpreted alongside these tests.